Covered recipient · General Payments record
ASHLEY NICOLE CLEMMONS KELLY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$467.31
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $330.57 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $109.06 | 5 |
| Lilly USA, LLC | $63.17 | 3 |
| ABBVIE INC. | $38.46 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.67 | 1 |
| GlaxoSmithKline, LLC. | $31.96 | 2 |
| PFIZER INC. | $23.29 | 1 |
| Supernus Pharmaceuticals, Inc. | $15.77 | 1 |
| Janssen Pharmaceuticals, Inc | $14.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.66 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107448902 | CMS |
| ABBVIE INC. | $21.80 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107448904 | CMS |
| GlaxoSmithKline, LLC. | $17.11 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115864384 | CMS |
| GlaxoSmithKline, LLC. | $14.85 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115969000 | CMS |
| Janssen Pharmaceuticals, Inc | $14.19 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078239437 | CMS |
| Lilly USA, LLC | $23.80 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135581374 | CMS |
| Lilly USA, LLC | $25.45 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135560838 | CMS |
| Lilly USA, LLC | $13.92 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135559618 | CMS |
| Novo Nordisk Inc | $24.14 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100579194 | CMS |
| Novo Nordisk Inc | $24.26 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100583006 | CMS |
| Novo Nordisk Inc | $20.73 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100372320 | CMS |
| Novo Nordisk Inc | $24.20 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100625030 | CMS |
| Novo Nordisk Inc | $15.73 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100356822 | CMS |
| PFIZER INC. | $23.29 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131895366 | CMS |
| Supernus Pharmaceuticals, Inc. | $15.77 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147894551 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.67 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137773373 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.